142 related articles for article (PubMed ID: 4007038)
1. Pharmacokinetic studies of cefoxitin in continuous ambulatory peritoneal dialysis.
Arvidsson A; Alván G; Tranaeus A; Malmborg AS
Eur J Clin Pharmacol; 1985; 28(3):333-7. PubMed ID: 4007038
[TBL] [Abstract][Full Text] [Related]
2. Cefoxitin disposition during peritoneal dialysis.
Greaves WL; Kreeft JH; Ogilvie RI; Richards GK
Antimicrob Agents Chemother; 1981 Feb; 19(2):253-5. PubMed ID: 7347560
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of intravenous and intraperitoneal cefotaxime in chronic ambulatory peritoneal dialysis.
Albin HC; Demotes-Mainard FM; Bouchet JL; Vincon GA; Martin-Dupont C
Clin Pharmacol Ther; 1985 Sep; 38(3):285-9. PubMed ID: 4028623
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of intravenous and intraperitoneal moxalactam in chronic ambulatory peritoneal dialysis.
Albin H; Ragnaud JM; Demotes-Mainard F; Vincon G; Wone C
Eur J Clin Pharmacol; 1986; 30(3):299-302. PubMed ID: 3732364
[TBL] [Abstract][Full Text] [Related]
5. Disposition of intravenous and intraperitoneal cefoxitin during chronic intermittent peritoneal dialysis.
Vlasses PH; D'Silva H; Rocci ML; Koplin JR; Bland JA; Siciliano EG; Ferguson RK
Am J Kidney Dis; 1983 Jul; 3(1):67-70. PubMed ID: 6869373
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of intravenous and intraperitoneal ceftriaxone in chronic ambulatory peritoneal dialysis.
Albin H; Ragnaud JM; Demotes-Mainard F; Vinçon G; Couzineau M; Wone C
Eur J Clin Pharmacol; 1986; 31(4):479-83. PubMed ID: 3816928
[TBL] [Abstract][Full Text] [Related]
7. Cefmenoxime kinetics during continuous ambulatory peritoneal dialysis.
Sica DA; Polk RE; Kerkering TM; Patterson P; Baggett J
Eur J Clin Pharmacol; 1986; 30(6):713-7. PubMed ID: 3464435
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of intravenous and intraperitoneal ceftazidime in chronic ambulatory peritoneal dialysis.
Demotes-Mainard F; Vinçon G; Ragnaud JM; Morlat P; Bannwarth B; Dangoumau J
J Clin Pharmacol; 1993 May; 33(5):475-9. PubMed ID: 8331207
[TBL] [Abstract][Full Text] [Related]
9. Peritoneal transport of vancomycin in 4 patients undergoing continuous ambulatory peritoneal dialysis.
Pancorbo S; Comty C
Nephron; 1982; 31(1):37-9. PubMed ID: 7110474
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of intravenous ceftizoxime in patients on continuous ambulatory peritoneal dialysis.
Johnson CA; Zimmerman SW; Bayer W; Craig WA
Clin Nephrol; 1985 Mar; 23(3):120-4. PubMed ID: 3857136
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis.
Burgess ED; Blair AD
Antimicrob Agents Chemother; 1983 Aug; 24(2):237-9. PubMed ID: 6314887
[TBL] [Abstract][Full Text] [Related]
12. Moxalactam kinetics during chronic ambulatory peritoneal dialysis.
Singlas E; Boutron HF; Merdjan H; Brocard JF; Pocheville M; Fries D
Clin Pharmacol Ther; 1983 Sep; 34(3):403-7. PubMed ID: 6224624
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of metronidazole in patients undergoing continuous ambulatory peritoneal dialysis.
Guay DR; Meatherall RC; Baxter H; Jacyk WR; Penner B
Antimicrob Agents Chemother; 1984 Mar; 25(3):306-10. PubMed ID: 6721462
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of oral cephradine in continuous ambulatory peritoneal dialysis patients.
Johnson CA; Welling PG; Zimmerman SW
Nephron; 1984; 38(1):57-61. PubMed ID: 6472532
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of intraperitoneal fluconazole during continuous cycling peritoneal dialysis.
Dahl NV; Foote EF; Searson KM; Fein JL; Kapoian T; Steward CA; Sherman RA
Ann Pharmacother; 1998 Dec; 32(12):1284-9. PubMed ID: 9876807
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of ornidazole in patients with renal insufficiency; influence of haemodialysis and peritoneal dialysis.
Merdjan H; Baumelou A; Diquet B; Chick O; Singlas E
Br J Clin Pharmacol; 1985 Feb; 19(2):211-7. PubMed ID: 3986079
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of intravenous and intraperitoneal fosfomycin in continuous ambulatory peritoneal dialysis.
Bouchet JL; Albin H; Quentin C; de Barbeyrac B; Vinçon G; Martin-Dupont P; Potaux L; Aparicio M
Clin Nephrol; 1988 Jan; 29(1):35-40. PubMed ID: 3383462
[TBL] [Abstract][Full Text] [Related]
18. Intraperitoneal and intravenous cefoperazone kinetics during continuous ambulatory peritoneal dialysis.
Keller E; Jansen A; Pelz K; Hoppe-Seyler G; Schollmeyer P
Clin Pharmacol Ther; 1984 Feb; 35(2):208-13. PubMed ID: 6692648
[TBL] [Abstract][Full Text] [Related]
19. Roxithromycin disposition in patients on continuous ambulatory peritoneal dialysis.
Lam YW; Flaherty JF; Yumena L; Schoenfeld PY; Gambertoglio JG
J Antimicrob Chemother; 1995 Jul; 36(1):157-63. PubMed ID: 8537262
[TBL] [Abstract][Full Text] [Related]
20. Elimination of absorbed aluminum in patients undergoing continuous ambulatory peritoneal dialysis.
Wilhelm M; Passlick J; Busch T; Ohnesorge FK
J Toxicol Clin Toxicol; 1988; 26(3-4):209-21. PubMed ID: 3418776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]